Document is current
Any future updates will be listed below
-
Authors
De Nardo, William https://orcid.org/0000-0002-1441-1295
Chan, Andrea Y.
Porter, Christopher J. H. https://orcid.org/0000-0003-3474-7551
Cao, Enyuan
Trevaskis, Natalie L. https://orcid.org/0000-0001-9538-549X
- License Information
-
More Information
Article History
Accepted: 27 February 2026
First Online: 16 March 2026
Competing interests
: C.J.H.P., N.L.T. and E.C. are inventors of the lymph-directing glyceride prodrug technology (PCT/AU2020/050997) including celecoxib prodrugs for the treatment of metabolic disease (PCT/US 17/753,936), that has been patented and licensed via a commercial agreement with Seaport Therapeutics. The other authors declare no competing interests.
